Table 4.
Variable | Univariate Analysis | Multivariate Analysis | ||||
---|---|---|---|---|---|---|
OR | 95% CI (Lower–Upper) | p | OR | 95% CI (Lower–Upper) | p | |
Age (increasing) | 1.008 | 0.999–1.017 | 0.081 | 0.989 | 0.970–1.009 | 0.267 |
Sex, male (female ref.) | 1.459 | 1.081–1.969 | 0.014 | 1.352 | 0.844–2.166 | 0.210 |
BMI (increasing) | 1.103 | 1.072–1.135 | <0.001 | 1.085 | 1.030–1.142 | 0.002 |
ASA Score (increasing) | 1.870 | 1.426–2.450 | <0.001 | 1.578 | 1.098–2.268 | 0.014 |
Increased SUA (dec./stable SUA ref.) | 10.068 | 7.154–14.170 | <0.001 | 4.698 | 2.943–7.498 | <0.001 |
Stage II | 1.628 | 1.138–2.328 | 0.008 | 1.280 | 0.844–1.940 | 0.245 |
Stage III | 2.412 | 1.585–3.669 | <0.001 | 1.543 | 0.949–2.511 | 0.080 |
Stage IV | 6.394 | 2.583–15.831 | <0.001 | 7.702 | 2.876–20.629 | <0.001 |
RN (PN ref.) | 3.040 | 2.157–4.283 | <0.001 | 1.620 | 1.084–2.421 | 0.019 |
de novo CKD stage III | 7.618 | 5.571–10.418 | <0.001 | 7.068 | 5.093–9.810 | <0.001 |